TUDOR INVESTMENT CORP ET AL - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$217,795
-88.8%
6,821
-83.3%
0.00%
-92.9%
Q3 2022$1,946,000
+351.5%
40,839
+443.2%
0.04%
+320.0%
Q1 2022$431,000
-89.5%
7,518
-84.0%
0.01%
-84.8%
Q3 2021$4,087,000
+505.5%
46,974
+795.4%
0.07%
+407.7%
Q2 2021$675,0005,2460.01%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders